You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diffuse Large B Cell Lymphoma CNS Relapse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma, CNS Metastasis Trial in Herlev

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Central Nervous System Metastasis
    • Herlev, Capital Region, Denmark
      Herlev Hopital
    Mar 21, 2022

    Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

    Recruiting
    • Diffuse Large B-cell Lymphoma Recurrent
    • Diffuse Large B Cell Lymphoma Refractory
    • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Oct 12, 2023

    Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

    Completed
    • Diffuse Large B Cell Lymphoma
    • +2 more
      • (no location specified)
      Dec 13, 2021

      Diffuse Large B Cell Lymphoma Trial in Guangzhou (Lenalidomide)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • Guangzhou, Guangdong, China
        Nanfang hospital
      Sep 3, 2020

      DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)

      Recruiting
      • Diffuse Large B-Cell Lymphoma
      • +3 more
      • Molecular Nanotechnology
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jun 2, 2022

      NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

      Suspended
      • NHL
      • +3 more
      • Minneapolis, Minnesota
      • +1 more
      Jan 31, 2023

      High-Dose Methotrexate Clearance in Diffuse Large B-Cell

      Recruiting
      • Central Nervous System Lymphoma
      • Diffuse Large B-Cell Lymphoma
      • Non-Interventional Study
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Sep 8, 2023

      Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

      Recruiting
      • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
        • Milan, Italy
          Ospedale San Raffaele
        Aug 29, 2023

        Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • +3 more
        • Low-Dose Decitabine plus anti-PD-1
        • Beijing, Beijing, China
          ChinaPLAGH
        Apr 18, 2023

        Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

        Recruiting
        • Recurrent Diffuse Large B-Cell Lymphoma
        • Refractory Diffuse Large B-cell Lymphoma
        • RC19D2 cell injection
        • Tianjin, Tianjin, China
          Hematology Hospital of the Chinese Academy of Medical Sciences
        Sep 14, 2023

        Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
        • (no location specified)
        Sep 5, 2023

        Relapsed or Refractory Diffuse Large B-cell Lymphoma Trial in Beijing (BEBT-908 for injection)

        Active, not recruiting
        • Relapsed or Refractory Diffuse Large B-cell Lymphoma
        • BEBT-908 for injection
        • Beijing, China
          Cancer Hospital Chinese Academy of Medical Sciences
        Oct 8, 2023

        Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)

        Not yet recruiting
        • Large B-cell Lymphoma
        • Diffuse Large B Cell Lymphoma
        • Homburg, Saarland, Germany
          Saarland University Medical Center
        Apr 19, 2023

        DLBCL Trial (Polatuzumab Vedotin)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • Polatuzumab Vedotin
        • (no location specified)
        Jul 12, 2023

        Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab vedotin and Rituximab)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Zanubrutinib, Polatuzumab vedotin and Rituximab
        • Shanghai, Shanghai, China
          Zhongshan Hospital，Fudan University
        Jul 10, 2023

        DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • Mitoxantrone Hydrochloride Liposome Injection
        • Jinan, Shandong, China
          Affiliated Cancer Hospital of Shandong First Medical University
        May 16, 2023

        Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation

        Recruiting
        • Lymphoma, Large B-Cell, Diffuse
          • Copenhagen, Denmark
            Department of Hematology, Rigshospitalet
          Jan 12, 2022

          Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

          Recruiting
          • Diffuse Large B Cell Lymphoma
          • Zanubrutinib, Polatuzumab Vedotin, Rituximab
          • Shanghai, Shanghai, China
            Zhongshan Hospital，Fudan University
          Jul 10, 2023

          Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)

          Not yet recruiting
          • Diffuse Large B-cell Lymphoma
          • (no location specified)
          Mar 9, 2023

          CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

          Active, not recruiting
          • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
          • DISEASE
          • (no location specified)
          May 4, 2023

          DLBCL Trial (Acalabrutinib, Rituximab)

          Not yet recruiting
          • Diffuse Large B-Cell Lymphoma
          • (no location specified)
          Jul 11, 2023

          DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

          Recruiting
          • DLBCL - Diffuse Large B Cell Lymphoma
          • Follicular Lymphoma
          • Lenalidomide combined with G-CHOP (LO CHOP)
          • Xiamen, Fujian, China
            Bing Xu
          Nov 28, 2023

          Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

          Not yet recruiting
          • Lymphoma, B-Cell
          • +6 more
          • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
          • Guayaquil, Guayas, Ecuador
            Instituto Oncológico Nacional Dr. Juan Tanca Marengo
          Apr 27, 2023

          Diffuse Large B Cell Lymphoma Trial in Rouen (Measure of the circulating tumor DNA)

          Not yet recruiting
          • Diffuse Large B Cell Lymphoma
          • Measure of the circulating tumor DNA
          • Rouen, France
            Centre Henri Becquerel
          Nov 17, 2023

          Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial

          Suspended
          • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
          • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jul 6, 2022